Registry for echocardiographic screening in pregnant women
Prospective Pakistan Registry of Echocardiographic Screening in Asymptomatic Pregnant Women
This study is testing how echocardiograms can help check the heart health of pregnant women during their routine doctor visits to catch any problems early.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Sex | Female |
| Sponsor | National Institute of Cardiovascular Diseases, Pakistan Academic / other |
| Locations | 1 site (Karachi, Sindh) |
| Trial ID | NCT06004544 on ClinicalTrials.gov |
What this trial studies
This registry enrolls obstetric patients attending routine antenatal visits to assess cardiovascular health during pregnancy. A standardized 2D transthoracic echocardiogram (TTE) protocol is utilized to evaluate heart function, including measurements of ejection fraction and left ventricular outflow tract gradients. Patients identified with significant cardiovascular issues are referred for further management at a specialized clinic. The study aims to enhance understanding of cardiovascular diseases in pregnant women and improve outcomes through early detection.
Who should consider this trial
Good fit: Ideal candidates for this registry are obstetric patients attending routine antenatal visits.
Not a fit: Patients who refuse consent for echocardiography or participation in the study will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to earlier identification and management of cardiovascular diseases in pregnant women, improving maternal and fetal health outcomes.
How similar studies have performed: While there is ongoing research in this area, this specific registry approach focusing on echocardiographic screening in asymptomatic pregnant women is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Obstetric patients attending routine antenatal visits Exclusion Criteria: * Patients refused to give consent for echocardiography or participation in the study
Where this trial is running
Karachi, Sindh
- National Institute of Cardiovascular Diseases (NICVD) — Karachi, Sindh, Pakistan (Recruiting)
Study contacts
- Principal investigator: Sabha Bhatti, MD — National Institute of Cardiovascular Diseases
- Study coordinator: Sabha Bhatti, MD
- Email: drsabhabhatti@gmail.com
- Phone: +92 335 5554346
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.